NCT05059665 - Performance Evaluation (Sensitivity/Specificity) of HelioLiver Test for Detection of HCC | Biotech Hunter

Enrollment

290

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions

Hepatocellular Carcinoma by AJCC Stage

Interventions

DIAGNOSTIC_TEST

Helio Liver Test

De-identified whole blood and serum samples are collected for the purpose of evaluating the performance (sensitivity/specificity) of the HelioLiver Test for the detection of hepatocellular carcinoma (HCC).

Trial Locations (2)

510060

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou